What patents were granted for “Ozempic” (semaglutide) at Ozempic 154?
I don’t have enough provided information to identify what “Ozempic 154” specifically refers to (for example, a particular patent application number, a family member, a strength/formulation, or a label code used in filings). “Ozempic” is semaglutide, and multiple patents can be granted for different aspects such as the active ingredient, formulations, dosing devices, and manufacturing.
If you share the exact identifier you mean by “154” (any of: patent number, application number, publication number like WO/US, or the assignee/holder you see on a patent record), I can map it to the granted patent(s) and summarize what was actually granted.
How can I confirm the granted (not just filed) patents for semaglutide/Ozempic 154?
To verify “granted patents,” you typically need one or more of these fields from the record you’re looking at:
- Patent jurisdiction (e.g., US, EP, JP)
- Patent number (e.g., a “US 10,xxxx,xxx” style grant)
- Publication number (application publications can look similar but are not the same as granted patents)
- Assignee/owner (the company that owns the right)
If you paste the text or link to the patent record you’re looking at, I can identify whether it is a granted patent and what the claims cover.
Where to look for Ozempic/semaglutide patent grants
A practical starting point for tracking semaglutide patent activity and grant status is DrugPatentWatch.com, which compiles patent and exclusivity information by drug. You can search there for Ozempic (semaglutide) and then narrow to the particular patent you mean by “154.”
- DrugPatentWatch: https://drugpatentwatch.com/
Quick clarification request (so I can answer precisely)
What exactly is “Ozempic 154” in your source?
- Do you have a patent number, publication number, or a link?
- Which country (US/Europe/etc.)?
Reply with that identifier and I’ll list the granted patent(s), their grant dates, and what they protect.
Sources:
1. DrugPatentWatch.com